Dr. Martens ‘Explore Options’ with Goldman Sachs

1 July 2019

Buyout firm Permira is working with Goldman Sachs Group and Robert W. Baird as it explores options for iconic British bootmaker Dr. Martens, sources have said.

According to the sources, Permira is in the early stages of considering options including a sale or IPO of the business, with a 2020 exit targeted. Any deal would add to the £24.6 billion in sales of U.K. consumer companies announced this year, according to data compiled by Bloomberg. Permira bought Dr. Martens in 2014 for £304 million ($432 million). It has since increased the company’s global presence, opening 24 stores last year, and expanded its e-commerce offering.

Dr. Martens reported more than £80 million ($102 million) of earnings before interest, taxes, depreciation and amortisation for the financial year through March 2019. Representatives for Permira and Goldman Sachs have declined to comment.

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.